AccScience Publishing / JCBP / Online First / DOI: 10.36922/JCBP025380096
Submit to JCBP
Cite this article
2
Download
66
Views
Journal Browser
Volume | Year
Issue
Search
Forthcoming Issue
Current Issue
View All
News and Announcements
View All
REVIEW ARTICLE

Managing cancer-related depression: Insights from patient and environmental perspectives in psycho-oncology

Yufei Wu1,2 ,  Pengyuan Liu1*
Show Less
1 Department of Oncology, Zhejiang Hospital, Hangzhou, Zhejiang, China
2 Department of Senior Division, Anglo-Chinese School (International) of Singapore, Singapore
JCBP, 025380096 https://doi.org/10.36922/JCBP025380096
Received: 20 September 2025 | Revised: 2 December 2025 | Accepted: 22 December 2025 | Published online: 7 January 2026
© 2026 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Download PDF
XML
Cite
Abstract

Cancer-related depression (CRD) is a psychological and psychiatric disorder commonly observed among cancer patients. Its onset and progression are closely associated with changes in tumor burden and disease status, and are further influenced by anti-cancer treatments, cancer-related comorbidities, medical ambience and environment, and various social factors. CRD exerts multiple direct and indirect adverse effects on cancer management, substantially impairing patients’ quality of life and long-term survival. With the development of psycho-oncology, CRD has become a prominent focus of academic research. However, comprehensive, forward-looking, integrative reviews on advances in the management of CRD remain scarce. In this review, we systematically searched and synthesized the latest evidence on CRD from the PubMed and Web of Science databases. We delineated a mechanistic axis of CRD that links tumor, immune, neural, and endocrine pathways, and propose an innovative clinical management framework conceptualized along a “tumor–psychology–ambience–society” axis. Overall, CRD is a common, clinically significant, and treatable condition that requires optimal management through close collaboration among oncologists, psychiatrists, psychologists, nursing teams, family members, and broader social support networks. Looking ahead, more in-depth basic research is needed to elucidate the mechanisms underlying CRD, identify more specific biomarkers, and define representative potential therapeutic targets. From a clinical perspective, large-scale real-world studies are warranted to validate whether CRD management strategies guided by the “tumor–psychology–ambience–society” framework can provide integrated benefits for both oncologic and psychological outcomes.

Graphical abstract
Keywords
Cancer-related depression
Quality of life
Hypothalamic–pituitary–adrenal axis
Psychotherapy
Bibliometrics
Funding
The study was supported by the Zhejiang Medical and Health Science and Technology Project (2024KY005).
Conflict of interest
The authors declare that they have no competing interests.
References
  1. Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12-49. doi: 10.3322/caac.21820

 

  1. Zhang X, Perry RJ. Metabolic underpinnings of cancer-related fatigue. Am J Physiol Endocrinol Metab. 2024;326(3):E290-E307. doi: 10.1152/ajpendo.00378.2023

 

  1. Swanton C, Bernard E, Abbosh C, et al. Embracing cancer complexity: Hallmarks of systemic disease. Cell. 2024;187(7):1589-1616. doi: 10.1016/j.cell.2024.02.009

 

  1. Zhu Q, Han Y, He Y, et al. Kaempferol improves breast cancer-related depression through the COX-2/PGE2 pathway. Front Biosci (Landmark Ed). 2023;28(11):311. doi: 10.31083/j.fbl2811311

 

  1. Yaniv D, Ramondetta LM, Cohen L, Amit M. Psilocybin-assisted psychotherapy for cancer-related anxiety and depression. Int J Gynecol Cancer. 2023;33(8):1327-1328. doi: 10.1136/ijgc-2023-004659

 

  1. Xia S, Zhu Y, Luo L, et al. Prognostic value of depression and anxiety on colorectal cancer-related mortality: A systematic review and meta-analysis based on univariate and multivariate data. Int J Colorectal Dis. 2024;39(1):45. doi: 10.1007/s00384-024-04619-6

 

  1. Carlson LE, Ismaila N, Addington EL, et al. Integrativeoncology care of symptoms of anxiety and depression in adults with cancer: Society for integrative oncology-ASCO guideline. J Clin Oncol. 2023;41(28):4562-4591. doi: 10.1200/JCO.23.00857

 

  1. Habimana S, Biracyaza E, Mpunga T, et al. Prevalence and associated factors of depression and anxiety among patients with cancer seeking treatment at the Butaro cancer center of excellence in Rwanda. Front Public Health. 2023;11:972360. doi: 10.3389/fpubh.2023.972360

 

  1. Xiao M, Chen X, Ji L, et al. Prevalence of frailty and its impact on quality of life in older patients with breast cancer: A prospective cross-sectional study. J Clin Nurs. 2025;34(9):3837-3847. doi: 10.1111/jocn.17599

 

  1. Li X, Hathaway CA, Small BJ, et al. Social isolation, depression, and anxiety among young adult cancer survivors: The mediating role of social connectedness. Cancer. 2024;130(23):4127-4137 doi: 10.1002/cncr.35508

 

  1. Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr. 2004;(32):57-71. doi: 10.1093/jncimonographs/lgh014

 

  1. Kulpa M, Ciuba A, Kosowicz M, et al. Assessment of anxiety and depression and selected psychosocial variables in cancer patients. Ocena związku lęku i depresji oraz wybranych zmiennych psychospołecznych u pacjentów onkologicznych. Psychiatr Pol. 2023;57(4):761-774. doi: 10.12740/pp/151067

 

  1. Linden W, Vodermaier A, Mackenzie R, Greig D. Anxiety and depression after cancer diagnosis: Prevalence rates by cancer type, gender, and age. J Affect Disord. 2012;141 (2-3):343-351. doi: 10.1016/j.jad.2012.03.025

 

  1. Vizin G, Szekeres T, Juhász A, et al. The role of stigma and depression in the reduced adherence among young breast cancer patients in Hungary. BMC Psychol. 2023;11(1):319. doi: 10.1186/s40359-023-01355-4

 

  1. Huang JW, Cao CA, Zheng WH, et al. The mechanism of cancer-depression comorbidity. Neuroscience. 2024;556: 25-30. doi: 10.1016/j.neuroscience.2024.07.040

 

  1. Cathomas F, Lin HY, Chan KL, et al. Circulating myeloid-derived MMP8 in stress susceptibility and depression. Nature. 2024;626(8001):1108-1115. doi: 10.1038/s41586-023-07015-2

 

  1. Spengler D, Rein T. Peripheral immune cell-derived matrix metalloprotease 8 (MMP8): Brain trafficking promotes depression-like behavior. Signal Transduct Target Ther. 2024;9(1):136. doi: 10.1038/s41392-024-01833-0

 

  1. Zhan D, Wang X, Zheng Y, et al. Integrative dissection of 5-hydroxytryptamine receptors-related signature in the prognosis and immune microenvironment of breast cancer. Front Oncol. 2023;13:1147189. doi: 10.3389/fonc.2023.1147189

 

  1. Li H, Marsland AL, Conley YP, Sereika SM, Bender CM. Genes involved in the HPA axis and the symptom cluster of fatigue, depressive symptoms, and anxiety in women with breast cancer during 18 months of adjuvant therapy. Biol Res Nurs. 2020;22(2):277-286. doi: 10.1177/1099800419899727

 

  1. Zeng T, Li J, Xie L, et al. Nrf2 regulates iron-dependent hippocampal synapses and functional connectivity damage in depression. J Neuroinflammation. 2023;20(1):212. doi: 10.1186/s12974-023-02875-x

 

  1. Kerkvliet CP, Truong TH, Ostrander JH, Lange CA. Stress sensing within the breast tumor microenvironment: How glucocorticoid receptors live in the moment. Essays Biochem. 2021;65(6):971-983. doi: 10.1042/EBC20200165

 

  1. Bennett JL, Jackson BN, Miller RJ, Tsui H, Martin- Caraballo M. IL-6 evoked biochemical changes in prostate cancer cells. Cytokine. 2023;161:156079. doi: 10.1016/j.cyto.2022.156079

 

  1. Noureddine LM, Trédan O, Hussein N, Badran B, Le Romancer M, Poulard C. Glucocorticoid receptor: A multifaceted actor in breast cancer. Int J Mol Sci. 2021;22(9):4446. doi: 10.3390/ijms22094446

 

  1. Khadka S, Druffner SR, Duncan BC, Busada JT. Glucocorticoid regulation of cancer development and progression. Front Endocrinol (Lausanne). 2023;14:1161768. doi: 10.3389/fendo.2023.1161768

 

  1. Polityńska B, Pokorska O, Wojtukiewicz AM, et al. Is depression the missing link between inflammatory mediators and cancer? Pharmacol Ther. 2022;240:108293. doi: 10.1016/j.pharmthera.2022.108293

 

  1. Zeng Z, Dong Y, Zou L, et al. GluCEST imaging and structural alterations of the bilateral hippocampus in first-episode and early-onset major depression disorder. J Magn Reson Imaging. 2023;58(5):1431-1440. doi: 10.1002/jmri.28651

 

  1. Corasaniti MT, Bagetta G, Morrone LA, et al. Efficacy of essential oils in relieving cancer pain: A systematic review and meta-analysis. Int J Mol Sci. 2023;24(8):7085. doi: 10.3390/ijms24087085

 

  1. Naser AY, Hameed AN, Mustafa N, et al. Depression and anxiety in patients with cancer: A cross-sectional study. Front Psychol. 2021;12:585534. doi: 10.3389/fpsyg.2021.585534

 

  1. Li XM, Xiao WH, Yang P, Zhao HX. Psychological distress and cancer pain: Results from a controlled cross-sectional survey in China. Sci Rep. 2017;7:39397. doi: 10.1038/srep39397

 

  1. Ding X, Lin Y, Chen C, et al. DNMT1 mediates chronic pain-related depression by inhibiting GABAergic neuronal activation in the central amygdala. Biol Psychiatry. 2023;94(8):672-684. doi: 10.1016/j.biopsych.2023.03.015

 

  1. Cai Y, Ge J, Pan ZZ. The projection from dorsal medial prefrontal cortex to basolateral amygdala promotes behaviors of negative emotion in rats. Front Neurosci. 2024;18:1331864. doi: 10.3389/fnins.2024.1331864

 

  1. Yu L, Li S, Wei J, Sun H, Yang C, Tan H. Association of serotonin transporter-linked polymorphic region (5-HTTLPR) with heat pain stimulation and postoperative pain in gastric cancer patients. Mol Pain. 2021;17:17448069211006606. doi: 10.1177/17448069211006606

 

  1. Zhao F, Sun Z, Niu W. Effect of Ward noise reduction technology combined with music therapy on negative emotions in inpatients undergoing gastric cancer radiotherapy: A retrospective study. Noise Health. 2023;25(119):257-263. doi: 10.4103/nah.nah_72_23

 

  1. Lindgren BM, Molin J, Lundström M, Strömbäck M, Salander Renberg E, Ringnér A. Does a new spatial design in psychiatric inpatient care influence patients’ and staff’s perception of their care/working environment? A study protocol of a pilot study using a single-system experimental design. Pilot Feasibility Stud. 2018;4:191. doi: 10.1186/s40814-018-0383-4

 

  1. Deegan A, Brennan C, Gallagher P, Lambert V, Dunne S. Social support and childhood cancer survivors: A systematic review (2006-2022). Psychooncology. 2023;32(6):819-833. doi: 10.1002/pon.6128

 

  1. Chambers A, Damone E, Chen YT, et al. Social support and outcomes in older adults with lung cancer. J Geriatr Oncol. 2022;13(2):214-219. doi: 10.1016/j.jgo.2021.09.009

 

  1. Silva C, McGovern C, Gomez S, Beale E, Overholser J, Ridley J. Can I count on you? Social support, depression and suicide risk. Clin Psychol Psychother. 2023;30(6):1407-1415. doi: 10.1002/cpp.2883

 

  1. Nausheen B, Kamal A. Familial social support and depression in breast cancer: An exploratory study on a Pakistani sample. Psychooncology. 2007;16(9):859-862. doi: 10.1002/pon.1136

 

  1. Tan M, Karabulutlu E. Social support and hopelessness in Turkish patients with cancer. Cancer Nurs. 2005;28(3): 236-240. doi: 10.1097/00002820-200505000-00013

 

  1. Moon TJ, Chih MY, Shah DV, Yoo W, Gustafson DH. Breast cancer survivors’ contribution to psychosocial adjustment of newly diagnosed breast cancer patients in a computer-mediated social support group. Journal Mass Commun Q. 2017;94(2):486-514. doi: 10.1177/1077699016687724

 

  1. Castillo EG, Shaner R, Tang L, et al. Improving depression care for adults with serious mental illness in underresourced areas: Community coalitions versus technical support. Psychiatr Serv. 2018;69(2):195-203. doi: 10.1176/appi.ps.201600514

 

  1. Kaltman S, Watson MR, Campoli M, et al. Treatment of depression and PTSD in primary care clinics serving uninsured low-income mostly Latina/o immigrants: A naturalistic prospective evaluation. Cultur Divers Ethnic Minor Psychol. 2019;25(4):579-589. doi: 10.1037/cdp0000251

 

  1. Ell K, Sanchez K, Vourlekis B, et al. Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecologic cancer. J Clin Oncol. 2005;23(13):3052-3060. doi: 10.1200/jco.2005.08.041

 

  1. Perez-Lopez R, Ghaffari Laleh N, Mahmood F, Kather JN. A guide to artificial intelligence for cancer researchers. Nat Rev Cancer. 2024;24(6):427-441. doi: 10.1038/s41568-024-00694-7

 

  1. Wu X, Li W, Tu H. Big data and artificial intelligence in cancer research. Trends Cancer. 2024;10(2):147-160. doi: 10.1016/j.trecan.2023.10.006

 

  1. Ale Y, Nainwal N. Progress and challenges in the diagnosis and treatment of brain cancer using nanotechnology. Mol Pharm. 2023;20(10):4893-4921. doi: 10.1021/acs.molpharmaceut.3c00554

 

  1. Li J, Li ZP, Ruan WJ, Wang W. Colorectal cancer screening: The value of early detection and modern challenges. World J Gastroenterol. 2024;30(20):2726-2730. doi: 10.3748/wjg.v30.i20.2726

 

  1. Tsimberidou AM, Kahle M, Vo HH, Baysal MA, Johnson A, Meric-Bernstam F. Molecular tumour boards - current and future considerations for precision oncology. Nat Rev Clin Oncol. 2023;20(12):843-863. doi: 10.1038/s41571-023-00824-4

 

  1. Rahnea-Nita RA, Rebegea LF, Dumitru M, et al. Anxiety and depression in advanced and metastatic lung cancer patients-correlations with performance status and type of treatment. Medicina (Kaunas). 2024;60(9):1472. doi: 10.3390/medicina60091472

 

  1. Ali YM, Sweeney J, Shen P, et al. Effect of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on quality of life in patients with peritoneal mesothelioma. Ann Surg Oncol. 2020;27(1):117-123. doi: 10.1245/s10434-019-07425-5

 

  1. Jiao J, Fan J, Zhang Y, Chen L. Efficacy and safety of ketamine to treat cancer pain in adult patients: A systematic review. J Pain Symptom Manage. 2024;67(3):e185-e210. doi: 10.1016/j.jpainsymman.2023.11.004

 

  1. Yuan T, Zhou Y, Wang T, Li Y, Wang Y. Impact research of pain nursing combined with hospice care on quality of life for patients with advanced lung cancer. Medicine (Baltimore). 2024;103(22):e37687. doi: 10.1097/md.0000000000037687

 

  1. Kim YP, Choi Y, Kim S, et al. Conventional cancer treatment alone or with regional hyperthermia for pain relief in lung cancer: A case-control study. Complement Ther Med. 2015;23(3):381-387. doi: 10.1016/j.ctim.2015.04.004

 

  1. Ariyafar T, Mahdavi SR, Geraily G, et al. Evaluating the effectiveness of combined radiotherapy and hyperthermia for the treatment response of patients with painful bony metastases: A phase 2 clinical trial. J Therm Biol. 2019;84: 129-135. doi: 10.1016/j.jtherbio.2019.06.003

 

  1. Capetti B, Conti L, Marzorati C, Grasso R, Ferrucci R, Pravettoni G. The application of tdcs to treat pain and psychocognitive symptoms in cancer patients: A scoping review. Neural Plast. 2024;2024:6344925. doi: 10.1155/2024/6344925

 

  1. Loprinzi C, Le-Rademacher JG, Majithia N, et al. Scrambler therapy for chemotherapy neuropathy: A randomized phase II pilot trial. Support Care Cancer. 2020;28(3):1183-1197. doi: 10.1007/s00520-019-04881-3

 

  1. Singleton AC, Raeside R, Hyun KK, et al. Electronic health interventions for patients with breast cancer: Systematic review and meta-analyses. J Clin Oncol. 2022;40(20): 2257-2270. doi: 10.1200/jco.21.01171

 

  1. Ream E, Hughes AE, Cox A, et al. Telephone interventions for symptom management in adults with cancer. Cochrane Database Syst Rev. 2020;6(6):CD007568. doi: 10.1002/14651858.CD007568.pub2

 

  1. Salsman JM, McLouth LE, Tooze JA, et al. An eHealth, positive emotion skills intervention for enhancing psychological well-being in young adult cancer survivors: Results from a multi-site, pilot feasibility trial. Int J Behav Med. 2023;30(5):639-650. doi: 10.1007/s12529-023-10162-5

 

  1. Campo RA, Bluth K, Santacroce SJ, et al. A mindful self-compassion videoconference intervention for nationally recruited posttreatment young adult cancer survivors: Feasibility, acceptability, and psychosocial outcomes. Support Care Cancer. 2017;25(6):1759-1768. doi: 10.1007/s00520-017-3586-y

 

  1. Ding X, Wu M, Zhang Y, et al. The prevalence of depression and suicidal ideation among cancer patients in mainland China and its provinces, 1994-2021: A systematic review and meta-analysis of 201 cross-sectional studies. J Affect Disord. 2023;323:482-489. doi: 10.1016/j.jad.2022.12.011

 

  1. Nigussie K, Tesfaye D, Abdisa L, et al. Suicidal ideation, attempt and associated factors among people with cancer attending cancer center, eastern Ethiopia. Front Psychiatry. 2023;14:1184921. doi: 10.3389/fpsyt.2023.1184921

 

  1. Giberson SA Jr., Hall BC, Jester B, et al. Suicidal ideation and depression among adolescent and young adult cancer patients. J Adolesc Young Adult Oncol. 2021;10(5):549-554. doi: 10.1089/jayao.2020.0180

 

  1. Akdogan O, Uyar GC, Yesilbas E, et al. Effect of a ChatGPT-based digital counseling intervention on anxiety and depression in patients with cancer: A prospective, randomized trial. Eur J Cancer. 2025;221:115408. doi: 10.1016/j.ejca.2025.115408

 

  1. Yan G, Zhang Q, Yan Y, et al. Trends in the prevalence and treatment of comorbid depression among US adults with and without cancer, 2005-2020. J Affect Disord. 2023;340: 743-750. doi: 10.1016/j.jad.2023.08.091

 

  1. Agrawal M, Richards W, Beaussant Y, et al. Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder. Cancer. 2024;130(7): 1137-1146. doi: 10.1002/cncr.35010

 

  1. Ng CG, Abousheishaa AA, Low SY, et al. A 6-month open-label study of vortioxetine among cancer patients with major depressive disorder (MDD). Asian Pac J Cancer Prev. 2023;24(8):2583-2591. doi: 10.31557/apjcp.2023.24.8.2583

 

  1. Bi X, Dai J, Li J. The effect of esketamine on postoperative anxiety and depression in patients with thyroid cancer: A randomized, double-blind, placebo-controlled, parallel-group trial. Medicine (Baltimore). 2025;104(18):e42284. doi: 10.1097/md.0000000000042284

 

  1. Orsolini L, Tomasetti C, Valchera A, et al. Current and future perspectives on the major depressive disorder: Focus on the new multimodal antidepressant vortioxetine. CNS Neurol Disord Drug Targets. 2017;16(1):65-92. doi: 10.2174/1871527315666161025140111

 

  1. Hung CM, Zeng BY, Zeng BS, et al. Cancer related fatigue-light therapy: Updated meta-analysis of randomised controlled trials. BMJ Support Palliat Care. 2023;13(e2):e437-e445. doi: 10.1136/bmjspcare-2021-003135

 

  1. LaRosa KN, MacArthur E, Wang F, et al. Light therapy for QoL/depression in AYA with cancer: A randomized trial. J Pediatr Psychol. 2022;47(3):306-317. doi: 10.1093/jpepsy/jsab098

 

  1. Liu W, Liu J, Ma L, Chen J. Effect of mindfulness yoga on anxiety and depression in early breast cancer patients received adjuvant chemotherapy: A randomized clinical trial. J Cancer Res Clin Oncol. 2022;148(9):2549-2560. doi: 10.1007/s00432-022-04167-y

 

  1. Yang LH, Duan PB, Hou QM, Wang XQ. Qigong exercise for patients with gastrointestinal cancer undergoing chemotherapy and at high risk for depression: A randomized clinical trial. J Altern Complement Med. 2021;27(9):750-759. doi: 10.1089/acm.2020.0531

 

  1. Ma X, Li SN, Chan DN. Effects of yoga on cancer-related fatigue, psychological distress, and quality of life among patients with cancer undergoing chemotherapy and/ or radiotherapy: A systematic review and meta-analysis. Cancer Nurs. 2025;48(3):200-212. doi: 10.1097/NCC.0000000000001293

 

  1. Takemura N, Cheung DST, Fong DYT, et al. Effectiveness of aerobic exercise and tai chi interventions on sleep quality in patients with advanced lung cancer: A randomized clinical trial. JAMA Oncol. 2024;10(2):176-184. doi: 10.1001/jamaoncol.2023.5248

 

  1. Zhou S, Yu M, Zhou Z, Wang L, Liu W, Dai Q. The effects of art therapy on quality of life and psychosomatic symptoms in adults with cancer: A systematic review and meta-analysis. BMC Complement Med Ther. 2023;23(1):434. doi: 10.1186/s12906-023-04258-4

 

  1. Ran R, Ying Y, Zhang W. Effects of music intervention on anxiety, depression symptoms and quality of life in breast cancer patients: A meta-analysis. Actas Esp Psiquiatr. 2023;51(6):250-261.

 

  1. Cheng P, Xu L, Zhang J, Liu W, Zhu J. Role of arts therapy in patients with breast and gynecological cancers: A systematic review and meta-analysis. J Palliat Med. 2021;24(3):443-452. doi: 10.1089/jpm.2020.0468

 

  1. Newland P, Bettencourt BA. Effectiveness of mindfulness-based art therapy for symptoms of anxiety, depression, and fatigue: A systematic review and meta-analysis. Complement Ther Clin Pract. 2020;41:101246. doi: 10.1016/j.ctcp.2020.101246

 

  1. Xu L, Cheng P, Wu Y, et al. The effects of art therapy on anxiety and depression in breast cancer patients: An updated meta-analysis. Eur J Cancer Care (Engl). 2020;29(5):e13266. doi: 10.1111/ecc.13266

 

  1. Koizumi T, Sugishita Y, Suzuki-Takahashi Y, et al. Oncofertility-related psycho-educational therapy for young adult patients with breast cancer and their partners: Randomized controlled trial. Cancer. 2023;129(16): 2568-2580. doi: 10.1002/cncr.34796

 

  1. Grüning Parache L, Vogel M, Meigen C, Kiess W, Poulain T. Family structure, socioeconomic status, and mental health in childhood. Eur Child Adolesc Psychiatry. 2024;33(7): 2377-2386. doi: 10.1007/s00787-023-02329-y

 

  1. Carek S, Emerson JF, Patel J. Primary care of adult cancer survivors. Am Fam Physician. 2024;110(1):37-44.

 

  1. Xia Y, Sun M, Huang H, Jin WL. Drug repurposing for cancer therapy. Signal Transduct Target Ther. 2024;9(1):92. doi: 10.1038/s41392-024-01808-1

 

  1. Ma P, Wang G, Men K, Li C, Gao N, Li L. Advances in clinical application of nanoparticle-based therapy for cancer treatment: A systematic review. Nano TransMed. 2024;3:100036. doi: 10.1016/j.ntm.2024.100036

 

  1. Grewal AK, Salar RK. Chitosan nanoparticle delivery systems: An effective approach to enhancing efficacy and safety of anticancer drugs. Nano TransMed. 2024;3(8):100040. doi: 10.1016/j.ntm.2024.100040

 

  1. Wang C, Wang Y, Tian W, et al. Application of nanomaterials with sulfur vacancy for cancer therapy. Nano TransMed. 2023;2(2-3):100007. doi: 10.1016/j.ntm.2023.100007
Next article in this issue
Share
Back to top
Journal of Clinical and Basic Psychosomatics, Electronic ISSN: 2972-4414 Print ISSN: 3060-8562, Published by AccScience Publishing
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here
Accept